Globant's (GLOB) organic growth is expected to improve in 2025 but foreign exchange remains a challenge, UBS said in a note sent Monday.
Contribution to overall growth from mergers and acquisitions will likely decline, the firm added in its Q4 earnings preview for the software development company.
Globant's Q4 2024 results are expected to show a decline in revenue from certain large-scale projects, which will be partially mitigated by higher US revenue, it said. UBS is forecasting revenue growth of 10.5% year-over-year for the quarter and 15.2% growth for full-year 2024, suggesting that topline numbers for the quarter and the year will be at the bottom of guidance ranges.
The investment firm trimmed its price target for the stock to $217 from $222, while maintaining a neutral rating.
"While FX translations should limit USD-growth, we note that GLOB's long exposure to USD helps it to navigate in a volatile FX scenario," UBS said.
Price: 212.91, Change: -0.41, Percent Change: -0.19
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。